TickerFactsScreenerDevelopers

ORAMED PHARMACEUTICALS INC. (ORMP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $1.51M2012: $4.43M2013: $2.27M2014: $1.76M2015: $3.21M2016: $3.91M2017: $3.97M2018: $5.00M2019: $3.33M2020: $19.30M2021: $77.25M2022: $40.46M2023: $9.05M2024: $54.42M2025: $45.95M$45.95M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$45.95M-15.6%
2024$54.42M+501.0%
2023$9.05M-77.6%
2022$40.46M-47.6%
2021$77.25M+300.3%
2020$19.30M+479.6%
2019$3.33M-33.4%
2018$5.00M+25.9%
2017$3.97M+1.6%
2016$3.91M+21.6%
2015$3.21M+82.3%
2014$1.76M-22.4%
2013$2.27M-48.7%
2012$4.43M+192.9%
2011$1.51M—